Voyager Therapeutics: Fourth Quarter Earnings Overview

Voyager Therapeutics Reports Fourth Quarter Financial Results

Voyager Therapeutics Inc., headquartered in Lexington, Massachusetts, announced a net loss of $27.4 million for the fourth quarter.

During this period, the company recorded a loss of $0.46 per share.

These figures were better than anticipated by analysts, as the consensus from six Zacks Investment Research analysts had projected a loss of $0.54 per share.

The gene therapy firm generated $15.3 million in revenue for the quarter, surpassing the $9.7 million expected by five Zacks analysts.

For the full year, Voyager Therapeutics reported a total loss of $119.7 million, or $2.04 per share, with annual revenue reaching $40.4 million.

Financial data for this article was compiled using information from Zacks Investment Research and produced by Automated Insights.